These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 26531813

  • 1. Renoprotective effects of berberine and its potential effect on the expression of β-arrestins and intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in streptozocin-diabetic nephropathy rats.
    Tang LQ, Ni WJ, Cai M, Ding HH, Liu S, Zhang ST.
    J Diabetes; 2016 Sep; 8(5):693-700. PubMed ID: 26531813
    [Abstract] [Full Text] [Related]

  • 2. Renoprotective effect of berberine via regulating the PGE2 -EP1-Gαq-Ca(2+) signalling pathway in glomerular mesangial cells of diabetic rats.
    Ni WJ, Tang LQ, Zhou H, Ding HH, Qiu YY.
    J Cell Mol Med; 2016 Aug; 20(8):1491-502. PubMed ID: 27098986
    [Abstract] [Full Text] [Related]

  • 3. Intervention with cilostazol attenuates renal inflammation in streptozotocin-induced diabetic rats.
    Wang F, Li M, Cheng L, Zhang T, Hu J, Cao M, Zhao J, Guo R, Gao L, Zhang X.
    Life Sci; 2008 Dec 19; 83(25-26):828-35. PubMed ID: 18983856
    [Abstract] [Full Text] [Related]

  • 4. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury.
    Liu W, Zhang X, Liu P, Shen X, Lan T, Li W, Jiang Q, Xie X, Huang H.
    Eur J Pharmacol; 2010 Jul 25; 638(1-3):150-5. PubMed ID: 20447389
    [Abstract] [Full Text] [Related]

  • 5. Renoprotective effects of berberine through regulation of the MMPs/TIMPs system in streptozocin-induced diabetic nephropathy in rats.
    Ni WJ, Ding HH, Zhou H, Qiu YY, Tang LQ.
    Eur J Pharmacol; 2015 Oct 05; 764():448-456. PubMed ID: 26192633
    [Abstract] [Full Text] [Related]

  • 6. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
    Xie X, Chang X, Chen L, Huang K, Huang J, Wang S, Shen X, Liu P, Huang H.
    Mol Cell Endocrinol; 2013 Dec 05; 381(1-2):56-65. PubMed ID: 23896433
    [Abstract] [Full Text] [Related]

  • 7. The renoprotective effects of berberine via the EP4-Gαs-cAMP signaling pathway in different stages of diabetes in rats.
    Yang Y, Ni W, Cai M, Tang L, Wei W.
    J Recept Signal Transduct Res; 2014 Dec 05; 34(6):445-55. PubMed ID: 24849498
    [Abstract] [Full Text] [Related]

  • 8. Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses.
    Chen J, Hou XF, Wang G, Zhong QX, Liu Y, Qiu HH, Yang N, Gu JF, Wang CF, Zhang L, Song J, Huang LQ, Jia XB, Zhang MH, Feng L.
    J Ethnopharmacol; 2016 Dec 04; 193():433-444. PubMed ID: 27664441
    [Abstract] [Full Text] [Related]

  • 9. Ameliorative effect of berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin.
    Wu D, Wen W, Qi CL, Zhao RX, Lü JH, Zhong CY, Chen YY.
    Phytomedicine; 2012 Jun 15; 19(8-9):712-8. PubMed ID: 22483555
    [Abstract] [Full Text] [Related]

  • 10. Effect of the oral iron chelator deferiprone in diabetic nephropathy rats.
    Zou C, Liu X, Liu R, Wang M, Sui M, Mu S, Li L, Ji L, Xie R.
    J Diabetes; 2017 Apr 15; 9(4):332-340. PubMed ID: 27121697
    [Abstract] [Full Text] [Related]

  • 11. Renoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats.
    Wang FL, Tang LQ, Yang F, Zhu LN, Cai M, Wei W.
    Mol Biol Rep; 2013 Mar 15; 40(3):2405-18. PubMed ID: 23196710
    [Abstract] [Full Text] [Related]

  • 12. β-Arrestins promote podocyte injury by inhibition of autophagy in diabetic nephropathy.
    Liu J, Li QX, Wang XJ, Zhang C, Duan YQ, Wang ZY, Zhang Y, Yu X, Li NJ, Sun JP, Yi F.
    Cell Death Dis; 2016 Apr 07; 7(4):e2183. PubMed ID: 27054338
    [Abstract] [Full Text] [Related]

  • 13. Protective effect of berberine on renal fibrosis caused by diabetic nephropathy.
    Li Z, Zhang W.
    Mol Med Rep; 2017 Aug 07; 16(2):1055-1062. PubMed ID: 29067464
    [Abstract] [Full Text] [Related]

  • 14. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
    Zhang MH, Feng L, Zhu MM, Gu JF, Jiang J, Cheng XD, Ding SM, Wu C, Jia XB.
    J Ethnopharmacol; 2014 Aug 07; 151(1):591-600. PubMed ID: 24269777
    [Abstract] [Full Text] [Related]

  • 15. Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats.
    Tone A, Shikata K, Sasaki M, Ohga S, Yozai K, Nishishita S, Usui H, Nagase R, Ogawa D, Okada S, Shikata Y, Wada J, Makino H.
    Diabetologia; 2005 Nov 07; 48(11):2402-11. PubMed ID: 16231067
    [Abstract] [Full Text] [Related]

  • 16. Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat.
    Lu HJ, Tzeng TF, Liou SS, Da Lin S, Wu MC, Liu IM.
    BMC Complement Altern Med; 2014 Mar 26; 14():110. PubMed ID: 24666993
    [Abstract] [Full Text] [Related]

  • 17. Berberine exerts renoprotective effects by regulating the AGEs-RAGE signaling pathway in mesangial cells during diabetic nephropathy.
    Qiu YY, Tang LQ, Wei W.
    Mol Cell Endocrinol; 2017 Mar 05; 443():89-105. PubMed ID: 28087385
    [Abstract] [Full Text] [Related]

  • 18. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway.
    Zhu L, Han J, Yuan R, Xue L, Pang W.
    Biol Res; 2018 Mar 31; 51(1):9. PubMed ID: 29604956
    [Abstract] [Full Text] [Related]

  • 19. Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy.
    Li JJ, Lee SH, Kim DK, Jin R, Jung DS, Kwak SJ, Kim SH, Han SH, Lee JE, Moon SJ, Ryu DR, Yoo TH, Han DS, Kang SW.
    Am J Physiol Renal Physiol; 2009 Jul 31; 297(1):F200-9. PubMed ID: 19369290
    [Abstract] [Full Text] [Related]

  • 20. Reno-protective effect of NECA in diabetic nephropathy: implication of IL-18 and ICAM-1.
    Elsherbiny NM, Abd El Galil KH, Gabr MM, Al-Gayyar MM, Eissa LA, El-Shishtawy MM.
    Eur Cytokine Netw; 2012 Jul 31; 23(3):78-86. PubMed ID: 22995127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.